A counterargument to the position of decriminalizing drugs with medicinal benefits, such as marijuana, is based on the need for a controlled regulatory framework. Here's an opposing viewpoint:

1. **Potential for Abuse**: While some drugs, like marijuana, may indeed have medicinal benefits, decriminalizing them without proper regulation could lead to misuse and abuse. Without safeguards in place, there is a risk that these substances could end up in the wrong hands or be used recreationally, potentially undermining their medical efficacy.

2. **Consistency in Regulation**: Opponents of this position argue that it's essential to maintain consistency in drug regulation. If some drugs are decriminalized solely for medicinal purposes, it could create confusion and difficulties in enforcement. A more comprehensive approach to drug policy that evaluates each substance individually may be necessary.

3. **Quality Control**: Medicinal drugs, including marijuana, often require strict quality control measures to ensure safety and effectiveness. Decriminalization without proper regulation might hinder the ability to control the quality and potency of these substances, which could jeopardize patient outcomes.

4. **Potential for Black Market**: Decriminalizing medicinal drugs without a well-defined regulatory framework could leave room for a black market to flourish. This unregulated market could expose patients to unsafe products and potentially criminal activities.

5. **Public Perception and Stigma**: Opponents argue that decriminalizing drugs, even for medicinal purposes, may contribute to a perception that drug use is more acceptable. This could make it more challenging to address substance abuse issues and addiction as a public health concern.

6. **Safety Concerns**: Some medicinal drugs have side effects or interactions with other medications that require careful monitoring. A regulated system can ensure that patients receive proper guidance, reducing the risk of adverse health effects.

In essence, this counterargument suggests that while recognizing the medicinal benefits of certain drugs is important, it should be done within a controlled regulatory framework to maintain safety, consistency, and oversight. Striking a balance between access to medication and preventing potential misuse is crucial in the broader discussion of drug policy.